Department of Pharmacy, Shraddha Institute of pharmacy, Washim, 444505.
Topical corticosteroids (TCs) are commonly prescribed for inflammatory skin conditions such as eczema, psoriasis, and dermatitis due to their anti-inflammatory and immunosuppressive properties. Despite their effectiveness, prolonged or improper use can lead to adverse effects like skin thinning, steroid-induced dermatitis, and systemic complications such as adrenal suppression. A study was conducted to assess awareness, misuse, and perceptions of TCs among 114 participants, including patients, pharmacists, and doctors. The results revealed significant gaps in knowledge and usage patterns. While 62% of participants had prior awareness of TCs, 37% lacked sufficient understanding, leading to misuse in 21.1% of cases. Common causes of misuse included a lack of awareness, pressure for quick results, and misleading advice from non-professionals. Notably, 17% of respondents admitted to unsupervised use, highlighting the need for better guidance from healthcare providers. Only 34.2% of participants felt adequately informed by healthcare professionals about the safe use of TCs. The study emphasized the importance of targeted education initiatives, such as awareness campaigns and patient workshops, to promote informed and safe usage. Furthermore, enhancing communication between healthcare providers and patients is critical to addressing misconceptions and preventing misuse. The findings underline the need for public awareness campaigns, improved prescription practices, and better access to accurate information to ensure the safe and effective use of topical steroids.
Topical corticosteroids (steroids) are one of the most widely prescribed and effective treatments for a variety of dermatological conditions, including eczema, psoriasis, dermatitis and allergic reactions. These medications, which are synthetic derivatives of corticosteroid hormones, act by reducing inflammation, suppressing immune responses and controlling symptoms such as redness, swelling and itching in the skin. Topical steroids are applied directly to the affected area, offering targeted relief with minimal systemic absorption.[1] They are available in different potencies, ranging from mild to super potent with various formulations, including creams, ointments, lotions and gels, designed to suit specific types of skin conditions. The choice of potency and formulation is often determined by the severity of the condition and the area of skin affected. Despite their effectiveness, the use of topical steroids has been associated with potential side effects such as skin thinning, delayed wound healing and the development of conditions like steroid-induced rosacea or perioral dermatitis. Long-term or excessive use can also lead to complications, making the optimal use of these medications a subject of ongoing research and clinical scrutiny.[2] This research project aims to examine the clinical applications of topical steroids, focusing on their efficacy, safety and the long-term impact on patients' skin health. The study will also explore alternative treatment strategies to mitigate the risks associated with their use. Understanding these aspects is crucial for improving treatment outcomes, ensuring patient safety and optimizing therapeutic strategies for managing chronic inflammatory skin diseases. By investigating the clinical practices surrounding topical steroid use, this research intends to contribute to better guidelines and enhance pharmacy practice in dermatology.[3]
Types of topical steroid
Classification
Pharmacological Properties and Mechanism of Action
TCs function by modulating inflammatory responses through the suppression of pro-inflammatory cytokines and the inhibition of inflammatory cell migration. Their efficacy is largely attributed to their ability to penetrate the skin barrier and bind to glucocorticoid receptors, leading to the transcriptional regulation of target genes involved in inflammation.[3]
Indications for Use
These agents are indicated for a wide array of dermatological conditions, including:?
Adverse Effects
METHODOLOGY
Estimated sample size – 100 people Basic statistical tool- Frequencies and Percentages, Mean, Median, Mode, Standard Deviation (SD)are proposed to be used in this study.[7,8]
Questionaries
Sr.no. |
Section Title |
Variables / Questions |
1 |
Demographic Information |
|
2 |
Prescription & Prior Knowledge |
|
3 |
Usage Patterns |
|
4 |
Information Sources & Awareness |
|
5 |
Perception of Risks |
|
6 |
Experience & Misuse |
|
7 |
Professional Support & Education |
|
Comparative Study
Parameter |
Study Findings |
Literature Insights |
Comparison |
Demographics |
Age group 18–24 (75.4%), balanced gender (55.3% male, 44.7% female), majority undergraduates (70.18%). |
Coondoo et al. (2014): Awareness influenced by education; young adults prone to misuse. |
Study findings align with global trends; young adults are the primary demographic at risk. |
Prescription Practices |
56.6% used steroids without prescriptions; only 43.4% received them. |
Sheth and Nair (2020): Unsupervised usage is common globally. |
Significant overlap in findings; unsupervised usage prevalent in both study and literature. |
Knowledge of Steroids |
62% had prior knowledge; 37% lacked awareness. |
Coondoo et al. (2014): Lack of awareness is a critical factor in misuse. |
Consistent lack of awareness highlights need for educational interventions. |
Adverse Effects |
20.1% experienced side effects like skin thinning and irritation. |
Kligman and Willis (2015): Dermatological side effects prevalent with misuse and prolonged use. |
Study findings reaffirm the dermatological risks noted in literature. |
Misuse Factors |
Lack of awareness (38.8%), quick results (28.9%), misleading advice (15.7%), easy access (14.9%). |
Grindlay and Williams (2015): Similar reasons for misuse, including insufficient education and urgency for results. |
Root causes of misuse show strong alignment with broader trends. |
Role of Healthcare Providers |
Only 34.2% felt adequately informed by healthcare providers; 36% were unsure. |
Harrison et al. (2015): Emphasize need for better doctor-patient communication to address misuse. |
Consistent communication gaps between healthcare providers and patients. |
Awareness Campaigns |
78.9% advocated for campaigns; preferred methods include awareness camps and provider counseling. |
Sheth and Nair (2020): Recommend targeted awareness programs to enhance safe usage. |
Strong agreement; educational initiatives are a common recommendation. |
Educational Initiatives |
Focused on awareness camps and provider-patient education during consultations. |
Grindlay and Williams (2015): Structured and interactive programs crucial for reducing misuse. |
Both emphasize multi-channel approaches for effective education. |
Impact of Misuse |
21.1% admitted misuse; pressure for results and lack of guidance identified as major contributors. |
Kligman and Willis (2015): Stress on stricter guidelines to minimize misuse and address root causes. |
Identical concerns highlight the need for regulatory and educational reforms. |
RESULT AND DISCUSSION
Parameter Analyzed for this Study are as follows
Study Population: 114 Participant.
The table presents the distribution of participants across different age groups in the study on awareness and misuse of topical steroids among patients and pharmacists. The majority of participants (75.4%) fall within the 18–24 age group, indicating that young adults form the primary demographic of this study. The 25–34 age group constitutes 13.2%, followed by the 35–44 age group with 10.5%. Only a small fraction (0.9%) of participants belong to the 45+ age group. This data highlights that the younger population is the most represented, which may influence the patterns of awareness and misuse analyzed in the study.
Table No 1. Age Group
Sr. No |
Age Group |
Frequency |
Percentage |
1 |
18-24 |
86 |
75.4% |
2 |
25-34 |
15 |
13.2% |
3 |
35-44 |
12 |
10.5% |
4 |
45+ |
01 |
0.9% |
Fig 1. Age Group
Profession
The table presents data on the distribution of responses collected from various groups based on their profession in a study about awareness and misuse of topical steroids. The majority of responses were recorded from pharmacists, who constituted 60.2% of the total participants (65 responses). Patients accounted for 33.3% of the responses, with 36 participants. Doctors formed the smallest group, contributing only 6.5% of the responses (42 participants). This distribution highlights that pharmacists play a crucial role in the supply and guidance regarding topical steroids. However, the significant percentage of patients indicates the need to focus on direct consumer education to reduce misuse. The relatively smaller proportion of doctors emphasizes their involvement in ensuring correct prescriptions and guidance for such medications.
Table No 2. Profession
Sr.no. |
Profession |
Response |
Percentage |
1 |
Pharmacist |
65 |
60.2 % |
2 |
Patient |
36 |
33.3 % |
3 |
Doctor |
42 |
6.5 % |
Fig 2. Profession
Prescription
Topical Steroid Prescription provides insights into the prescription practices of topical steroids among participants. The findings reveal that 43.4% of the respondents (49 individuals) reported receiving prescriptions for topical steroids, while the remaining 56.6% (64 individuals) indicated that they had not received such prescriptions. This indicates that a significant proportion of participants had not been prescribed topical steroids, which may reflect a gap in the regulated use or a preference for over-the-counter availability of these medications.
Table No 3. Prescription
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
49 |
43 % |
2 |
No |
64 |
56 % |
3 |
Not respond |
1 |
1 % |
Fig 3. Prescription
Frequency Of Topical Steriod Use
The table illustrates the distribution of responses regarding the frequency of topical steroid use among the surveyed individuals. A significant proportion of participants (47%) reported that they had never used topical steroids. However, 42% admitted to occasional usage, indicating potential sporadic or situational reliance. Weekly usage was noted by 9% of the participants, while only 0.9% reported daily application, reflecting a small but concerning group with frequent usage. Additionally, 1.1% of respondents chose not to answer the question.
Table No 4. Frequency Of Topical Steroid Use
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Never |
53 |
47 % |
2 |
Occasionally |
47 |
42 % |
3 |
Weekly |
11 |
9 % |
4 |
Daily |
1 |
0.9 % |
5 |
Not respond |
2 |
1.1 % |
Fig 4. Frequency Of Topical Steroid Use
Steroid Purpose Insights
A survey was conducted to assess the level of awareness regarding the main purpose of topical steroids among patients and pharmacists. A total of 114 responses were collected. Of these, 76 participants (66.7%) acknowledged awareness of the purpose of topical steroids, indicating a relatively high level of knowledge. However, 34 participants (29.8%) reported not being aware of their main purpose, highlighting a gap in understanding. Additionally, 4 respondents (3.5%) did not provide a response to the question. These results suggest that while a majority of participants have an understanding of topical steroids, there remains a significant portion with limited knowledge or awareness, which may contribute to misuse or improper application of these medications.
Table No 5. Steroid Purpose Insights
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
76 |
66.7 % |
2 |
No |
34 |
29.8 % |
3 |
Not respond |
4 |
3.5 % |
Fig 5. Steroid Purpose Insights
Source Of Information
The chart highlights the sources of information regarding topical steroid usage among patients and pharmacists. The majority of respondents (41, 35.9%) reported that they rely on doctors or healthcare providers for guidance, making them the primary source of information. Pharmacists were the second most common source, cited by 32 respondents (28.6%). Additionally, 19 participants (16.3%) turned to the internet for information, while 17 respondents (14.9%) relied on family and friends. A smaller proportion, 3 respondents (2.6%), sought information from social media, and 2 respondents (1.7%) did not provide an answer
Table No 6. Source of Information
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Doctor/Healthcare provider |
41 |
35.9 % |
2 |
Internet |
19 |
16.3 % |
3 |
Social media |
03 |
2.6 % |
4 |
Family/friends |
17 |
14.9 % |
5 |
Pharmacist |
32 |
28.6 % |
4 |
Not Respond |
02 |
1.7 % |
Fig 6. Source of Information
Percepti0n Of Long-Term Skin Damage from Topical Steroid Misuse
The chart shows that 51.3% of respondents are aware of long-term skin damage from topical steroid misuse, 35.9% are unsure, 12% deny the risk, and 0.8% did not respond. This highlights the need for better awareness and education on the safe use of topical steroids among patients and pharmacists.
Table No 7. Perception of Long-Term Skin Damage from Topical Steroid Misuse
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
58 |
51.3 % |
2 |
Not sure |
41 |
35.9 % |
3 |
No |
14 |
12 % |
4 |
Not respond |
1 |
0.8 % |
Fig 7. Perception of Long-Term Skin Damage from Topical Steroid Misuse
Side Effects
The data highlights the occurrence of side effects from topical steroid use among patients and pharmacists. While 77.3% of respondents reported no side effects, 20.1% experienced adverse effects, and 2.6% did not disclose their experience. This emphasizes the need for increased awareness and proper guidance to minimize risks associated with topical steroid misuse.
Table No 8. Side effects
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
23 |
20.1 % |
2 |
No |
88 |
77.3 % |
3 |
Not respond |
3 |
2.6 % |
Fig 8. Side effects
Misuse Of Topical Steroid
The data illustrates the misuse of topical steroids among patients and pharmacists. While 77.3% of respondents denied misuse, 21.1% admitted to it, and 1.6% chose not to respond. This indicates that a significant minority engages in improper use, emphasizing the need for targeted awareness campaigns and stricter guidance from healthcare providers to prevent misuse.
Table No 9. Misuse of topical steroid
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
24 |
21.1 % |
2 |
No |
88 |
77.3 % |
3 |
Not respond |
2 |
1.6 % |
Fig 9. Misuse of topical steroid
Guidance Of Healthcare Professional on Topical Steroid
The survey on topical steroid awareness highlights a concerning knowledge gap. When asked if healthcare professionals adequately inform patients about proper use, opinions were divided: 34.2% believed they do, 29.8% thought they don't, and 36% were uncertain. This ambiguity underscores the need for enhanced patient education and awareness initiatives to ensure safe and effective topical steroid use.
Table No 10. Guidance of healthcare professional on topical steroid
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
39 |
34.2 % |
2 |
No |
34 |
29.8 % |
3 |
Not sure |
41 |
36 % |
Fig 10. Guidance Of Healthcare Professional on Topical Steroid
Raising Awareness About Topical Steroid
An overwhelming 78.9% of respondents advocated for increased public awareness campaigns about the risks of topical steroid misuse, highlighting a strong demand for education and prevention efforts. In contrast, only 6.3% disagreed, while 14% remained uncertain, and 1 respondent didn't answer. This resounding call to action underscores the need for targeted awareness initiatives to inform the public about the potential dangers of topical steroid misuse.
Table No 18. Raising awareness about topical steroid
Sr.no. |
Response |
Frequency |
Percentage |
1 |
Yes |
90 |
78.9 % |
2 |
No |
07 |
6.3 % |
3 |
Not sure |
16 |
14 % |
4 |
Not respond |
1 |
0.8 % |
Fig 19. Raising Awareness About Topical Steroid
Based on the responses collected, emphasize two key strategies:
Awareness camps serve as an impactful platform to reach both patients and pharmacists, offering education on the correct use of topical steroids through live demonstrations, interactive sessions and Q\&A opportunities. These camps aim to dispel misconceptions and promote informed decision-making. Furthermore, healthcare providers play a pivotal role in this education by explaining the appropriate dosage, frequency, and duration of use during consultations. They should also highlight the potential side effects, such as skin thinning or irritation, to underscore the importance of adhering to medical guidance. These combined efforts are crucial for improving awareness and fostering the safe and effective use of topical steroids.
CONCLUSION
The study concludes that while topical corticosteroids are highly effective for treating inflammatory skin conditions, their misuse and lack of proper guidance significantly contribute to adverse effects and patient safety concerns. A considerable proportion of participants demonstrated limited awareness of the appropriate use of these medications, with unsupervised application and reliance on non-professional advice being key factors in misuse. This highlights the critical need for targeted educational initiatives, public awareness campaigns, and enhanced communication between healthcare providers and patients. By promoting informed usage and implementing stricter prescription guidelines, the safe and effective use of topical corticosteroids can be ensured, ultimately improving patient outcomes and minimizing potential risks.
REFERENCES
Prajval Tidke*, Dr. Asawali Pawar, Swati Deshmukh, Topical Steroid: A Study on Awareness, Misuse and Perceptions Among Patients and Pharmacists, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 3312-3324. https://doi.org/10.5281/zenodo.15469268